Impact of Low Molecular Weight Heparin on Overall Survival in Patients with Advanced Lung Cancer : A Retrospective Study

@inproceedings{Hassan2017ImpactOL,
  title={Impact of Low Molecular Weight Heparin on Overall Survival in Patients with Advanced Lung Cancer : A Retrospective Study},
  author={Rammey Hassan and Shuchi Gulati and Yellu Mahender and Ihab Eldessouki and Nabeela Iffat Siddiqi and Changchun Xie and Jane M Pruemer and Nagla Abdel Karim},
  year={2017}
}
Low Molecular Weight Heparin (LMWH) is approved for treatment of and secondary prophylaxis against thromboembolic events in patients with cancer. However, its role in improving Overall Survival (OS) remains unclear. A retrospective study to evaluate effect of LMWH on OS in advanced lung cancer was conducted by retrospectively identifying patients with advanced lung cancer (stage IIIA, IIIB and IV) including non-small cell, small cell and rare histopathologic subtypes from 2004 to 2014. Patients… CONTINUE READING
0 Extracted Citations
12 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 12 references

Similar Papers

Loading similar papers…